These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 35582640)
1. Effect of the structure of ginsenosides on the Chen C; Xia J; Ren H; Wang A; Zhu Y; Zhang R; Gan Z; Wang J Asian J Pharm Sci; 2022 Mar; 17(2):219-229. PubMed ID: 35582640 [TBL] [Abstract][Full Text] [Related]
2. Novel ginsenoside-based multifunctional liposomal delivery system for combination therapy of gastric cancer. Hong C; Wang D; Liang J; Guo Y; Zhu Y; Xia J; Qin J; Zhan H; Wang J Theranostics; 2019; 9(15):4437-4449. PubMed ID: 31285771 [TBL] [Abstract][Full Text] [Related]
3. Paclitaxel-loaded ginsenoside Rg3 liposomes for drug-resistant cancer therapy by dual targeting of the tumor microenvironment and cancer cells. Zhu Y; Wang A; Zhang S; Kim J; Xia J; Zhang F; Wang D; Wang Q; Wang J J Adv Res; 2023 Jul; 49():159-173. PubMed ID: 36167294 [TBL] [Abstract][Full Text] [Related]
4. Targeting therapy and tumor microenvironment remodeling of triple-negative breast cancer by ginsenoside Rg3 based liposomes. Xia J; Zhang S; Zhang R; Wang A; Zhu Y; Dong M; Ma S; Hong C; Liu S; Wang D; Wang J J Nanobiotechnology; 2022 Sep; 20(1):414. PubMed ID: 36109762 [TBL] [Abstract][Full Text] [Related]
5. Multifunctional ginsenoside Rg3-based liposomes for glioma targeting therapy. Zhu Y; Liang J; Gao C; Wang A; Xia J; Hong C; Zhong Z; Zuo Z; Kim J; Ren H; Li S; Wang Q; Zhang F; Wang J J Control Release; 2021 Feb; 330():641-657. PubMed ID: 33359582 [TBL] [Abstract][Full Text] [Related]
6. Ginsenoside Rh2-Based Multifunctional Liposomes for Advanced Breast Cancer Therapy. Hong C; Wang A; Xia J; Liang J; Zhu Y; Wang D; Zhan H; Feng C; Jiang X; Pan J; Wang J Int J Nanomedicine; 2024; 19():2879-2888. PubMed ID: 38525007 [TBL] [Abstract][Full Text] [Related]
7. One Stone Four Birds: A Novel Liposomal Delivery System Multi-functionalized with Ginsenoside Rh2 for Tumor Targeting Therapy. Hong C; Liang J; Xia J; Zhu Y; Guo Y; Wang A; Lu C; Ren H; Chen C; Li S; Wang D; Zhan H; Wang J Nanomicro Lett; 2020 Jun; 12(1):129. PubMed ID: 34138128 [TBL] [Abstract][Full Text] [Related]
8. [Ginsenoside Rg_3 based liposomes target delivery of dihydroartemisinin and paclitaxel for treatment of triple-negative breast cancer]. Liu H; Liu Y; Li N; Zhang GQ; Wang M Zhongguo Zhong Yao Za Zhi; 2023 Jul; 48(13):3472-3484. PubMed ID: 37474984 [TBL] [Abstract][Full Text] [Related]
9. Enhanced anti-glioma activity of annonaceous acetogenins based on a novel liposomal co-delivery system with ginsenoside Rh2. Ao H; Song H; Li J; Wang X Drug Deliv; 2024 Dec; 31(1):2324716. PubMed ID: 38555735 [TBL] [Abstract][Full Text] [Related]
10. [Analysis of parameters of serum concentration and pharmacokinetic of liposome and aqueous solution of toatal ginsenoside of ginseng stems and leaves in rats]. Zha L; Zhao Y; Zhu HY; Cai EB; Liu SL; Yang H; Zhao Y; Gao YG; Zhang LX Zhongguo Zhong Yao Za Zhi; 2017 May; 42(10):1957-1963. PubMed ID: 29090557 [TBL] [Abstract][Full Text] [Related]
11. Assessment of a New Ginsenoside Rh2 Nanoniosomal Formulation for Enhanced Antitumor Efficacy on Prostate Cancer: An in vitro Study. Zare-Zardini H; Alemi A; Taheri-Kafrani A; Hosseini SA; Soltaninejad H; Hamidieh AA; Haghi Karamallah M; Farrokhifar M; Farrokhifar M Drug Des Devel Ther; 2020; 14():3315-3324. PubMed ID: 32884236 [TBL] [Abstract][Full Text] [Related]
12. Ginsenosides Rg3 and Rh2 inhibit the activation of AP-1 and protein kinase A pathway in lipopolysaccharide/interferon-gamma-stimulated BV-2 microglial cells. Bae EA; Kim EJ; Park JS; Kim HS; Ryu JH; Kim DH Planta Med; 2006 Jun; 72(7):627-33. PubMed ID: 16673329 [TBL] [Abstract][Full Text] [Related]
13. Glycosyltransformation of ginsenoside Rh2 into two novel ginsenosides using recombinant glycosyltransferase from Wang DD; Kim YJ; Baek NI; Mathiyalagan R; Wang C; Jin Y; Xu XY; Yang DC J Ginseng Res; 2021 Jan; 45(1):48-57. PubMed ID: 33437156 [TBL] [Abstract][Full Text] [Related]
14. Production of Rare Ginsenosides Rg3 and Rh2 by Endophytic Bacteria from Yan H; Jin H; Fu Y; Yin Z; Yin C J Agric Food Chem; 2019 Aug; 67(31):8493-8499. PubMed ID: 31310523 [TBL] [Abstract][Full Text] [Related]
15. Characterizing a full spectrum of physico-chemical properties of (20S)- and (20R)-ginsenoside Rg3 to be proposed as standard reference materials. Kim IW; Sun WS; Yun BS; Kim NR; Min D; Kim SK J Ginseng Res; 2013 Mar; 37(1):124-34. PubMed ID: 23717166 [TBL] [Abstract][Full Text] [Related]
16. Versatile ginsenoside Rg3 liposomes inhibit tumor metastasis by capturing circulating tumor cells and destroying metastatic niches. Xia J; Ma S; Zhu X; Chen C; Zhang R; Cao Z; Chen X; Zhang L; Zhu Y; Zhang S; Li S; Gu G; Wei X; Yu K; Wang J Sci Adv; 2022 Feb; 8(6):eabj1262. PubMed ID: 35148178 [TBL] [Abstract][Full Text] [Related]
17. Neuroprotective Effects of Ginsenosides against Cerebral Ischemia. Cheng Z; Zhang M; Ling C; Zhu Y; Ren H; Hong C; Qin J; Liu T; Wang J Molecules; 2019 Mar; 24(6):. PubMed ID: 30897756 [TBL] [Abstract][Full Text] [Related]
18. (20S)-Protopanaxadiol Ginsenosides Induced Cytotoxicity via Blockade of Autophagic Flux in HGC-27 Cells. Han Q; Han L; Tie F; Wang Z; Ma C; Li J; Wang H; Li G Chem Biodivers; 2020 Jul; 17(7):e2000187. PubMed ID: 32384197 [TBL] [Abstract][Full Text] [Related]
19. Development of liposomal Ginsenoside Rg3: formulation optimization and evaluation of its anticancer effects. Yu H; Teng L; Meng Q; Li Y; Sun X; Lu J; J Lee R; Teng L Int J Pharm; 2013 Jun; 450(1-2):250-8. PubMed ID: 23628402 [TBL] [Abstract][Full Text] [Related]
20. Influence of Wang M; Li Q; Li S; Zhao Y; Jiang X; He S; Liu J Foods; 2023 Oct; 12(21):. PubMed ID: 37959065 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]